4DMedical Secures CE Mark and $83M to Accelerate European Lung Imaging Rollout

• CT:VQ™ receives CE Mark, enabling commercial use across the European Union
• $83 million private placement completed at $5.90 per share to fund EU expansion
• Placement represents 2.45% increase in shares on issue and a 6.1% discount to last close
• CT:VQ™ already deployed at six leading U.S. academic medical centres